title: Radioimmunotherapy: strategies for the future in indolent and aggressive lymphoma.
abstract: The conjugation of radioisotopes to monoclonal antibodies, or radioimmunotherapy (RIT), is a highly active treatment in non-Hodgkin's lymphoma. RIT has demonstrated high response rates and durable remissions in extensively pretreated patients and has proved highly effective as consolidation after induction chemotherapy in the first-line therapy of follicular lymphoma. Early-phase clinical trials have shown highly promising results using RIT as part of conditioning regimens in patients who are to undergo transplantation and as consolidation after chemotherapy in patients with aggressive lymphomas. Recent data suggest that integrating RIT with immunochemotherapy and transplant conditioning regimens may further improve outcomes for patients.
authors.affiliation: School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester M20 4BX, United Kingdom.
authors.forename: Waleed
authors.initials: W
authors.lastname: Alduaij
authors.forename: Tim M
authors.initials: TM
authors.lastname: Illidge
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008223:Lymphoma / Q000473:pathology / Q000532:radiotherapy* / Q000628:therapy; D016499:Radioimmunotherapy / Q000379:methods*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal
references.citation: J Clin Oncol. 2003 Apr 1;21(7):1263-70
references.pmid: 12663713
references.citation: N Engl J Med. 1984 Dec 6;311(23):1471-5
references.pmid: 6548796
references.citation: J Clin Oncol. 2005 Feb 1;23(4):712-9
references.pmid: 15613695
references.citation: Semin Radiat Oncol. 2000 Apr;10(2):73-93
references.pmid: 10727597
references.citation: J Clin Oncol. 2008 Jan 1;26(1):90-5
references.pmid: 18025438
references.citation: J Clin Oncol. 2002 Aug 1;20(15):3262-9
references.pmid: 12149300
references.citation: Leuk Lymphoma. 2006 Apr;47(4):629-36
references.pmid: 16690521
references.citation: J Clin Oncol. 2009 Apr 1;27(10):1653-9
references.pmid: 19255322
references.citation: Blood. 2008 Aug 1;112(3):830-5
references.pmid: 18502830
references.citation: J Clin Oncol. 1999 Dec;17(12):3793-803
references.pmid: 10577851
references.citation: Blood. 2004 Jun 15;103(12):4429-31
references.pmid: 15016644
references.citation: Semin Oncol. 1999 Oct;26(5 Suppl 14):58-65
references.pmid: 10561019
references.citation: Blood. 2006 Nov 15;108(10):3295-301
references.pmid: 16873669
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):7088-94
references.pmid: 18981007
references.citation: J Clin Oncol. 1998 Oct;16(10):3270-8
references.pmid: 9779701
references.citation: J Clin Oncol. 2001 Oct 1;19(19):3918-28
references.pmid: 11579112
references.citation: Cancer Sci. 2009 Jan;100(1):158-64
references.pmid: 19018755
references.citation: Blood. 2009 Apr 23;113(17):3891-5
references.pmid: 19182204
references.citation: J Clin Oncol. 2005 Oct 20;23(30):7565-73
references.pmid: 16186600
references.citation: J Clin Oncol. 2005 Aug 20;23(24):5696-704
references.pmid: 16110029
references.citation: N Engl J Med. 2005 Feb 3;352(5):441-9
references.pmid: 15689582
references.citation: Br J Haematol. 2000 Mar;108(4):679-88
references.pmid: 10792269
references.citation: Blood. 2000 Nov 1;96(9):2934-42
references.pmid: 11049969
references.citation: Cancer Biother Radiopharm. 2007 Oct;22(5):684-91
references.pmid: 17979571
references.citation: J Clin Oncol. 2008 Nov 10;26(32):5156-64
references.pmid: 18854568
references.citation: J Clin Oncol. 2003 Jul 1;21(13):2474-80
references.pmid: 12829665
references.citation: N Engl J Med. 2002 Jan 24;346(4):235-42
references.pmid: 11807147
references.citation: Radiother Oncol. 1984 Dec;2(4):317-23
references.pmid: 6395213
references.citation: J Clin Oncol. 2002 May 15;20(10):2453-63
references.pmid: 12011122
references.citation: Blood. 2007 Jul 1;110(1):54-8
references.pmid: 17387223
references.citation: Blood. 2003 Sep 1;102(5):1606-12
references.pmid: 12738671
references.citation: Blood. 2009 Feb 12;113(7):1412-21
references.pmid: 19074729
references.citation: N Engl J Med. 2004 May 20;350(21):2191-3
references.pmid: 15118072
references.citation: J Clin Oncol. 1998 Aug;16(8):2825-33
references.pmid: 9704735
references.citation: J Clin Oncol. 1996 Apr;14(4):1282-90
references.pmid: 8648385
references.citation: J Natl Cancer Inst. 2007 May 2;99(9):706-14
references.pmid: 17470738